Heart, liver, and plasma levels of very-long-chain C24 ceramides are found to be reduced in obesity and diabetes, and their replacement is seemingly metabolically beneficial, increasing weight loss, insulin sensitivity, glucose tolerance, and FFA oxidation [219]. This evidence concerns the gene INS and obesity disorder.